PPARG and metabolic syndrome: Moreover, biochanin A may improve lipid profile as a peroxisome proliferator-activated receptor gamma (PPARγ) agonist and provide beneficial effects on metabolic syndrome such as hyperglycaemia (Wang et al., 2014; Park et al., 2016).